Exelixis (NASDAQ:EXEL) reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.79 by 15.19 percent. This is a 21.33 percent increase over earnings of $0.75 per share from the same period last year. The company reported quarterly sales of $628.700 million which missed the analyst consensus estimate of $635.951 million by 1.14 percent. This is a 10.63 percent increase over sales of $568.300 million the same period last year.